Skip to content

The Impact of Blue and Red Light Therapy on the Facial Skin Microbiome in Oily Skin

The Impact of Blue and Red Light Therapy on the Facial Skin Microbiome in Oily Skin

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260711003
Enrollment
30
Registered
2026-07-11
Start date
2026-07-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial oily skin Phototherapy, Light emission diode, Red light, Blue light, Microbiota, Skin microbiology, Sebum, Oily Skin

Interventions

Participants in this arm will receive 415 nm blue LED light therapy applied to the entire facial area. The treatment will be administered twice weekly for 4 consecutive weeks, totaling 8 sessions. Eac
Experimental Device,Active Comparator Device
415 nm Blue Light Therapy,633 nm Red Light Therapy

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Presentation of oily skin conditions, 2. Fitzpatrick skin phototypes 3 to 4

Exclusion criteria

Exclusion criteria: 1. Active inflammatory skin diseases in the treatment area, 2. Concurrent active cutaneous infections (viral, fungal, or bacterial) in the treatment area, 3. History of using topical antibiotics and non-antibiotic acne treatments within 1 month prior to study enrollment, 4. Concomitant use of oral retinoids, spironolactone or oral contraceptives within 6 months prior to study enrollment, 5. History of facial treatment with dermal fillers or biostimulators in the treatment area within 1 year prior to study enrollment, 6. History of botulinum toxin injection in the facial area within 6 months prior to study enrollment, 7. History of facial surgery within 6 months prior to study enrollment, 8. Previous treatment with lasers, Intense Pulsed Light or other phototherapies within 3 months prior to study enrollment, 9. Currently pregnant or lactating, 10. Diagnosis of photosensitive dermatosis, including Systemic Lupus Erythematosus, 11. Diagnosis of Polycystic Ovary Syndrome, 12. History of epilepsy or photosensitive seizures, 13. Presence of retinal diseases, 14. History of hypersensitivity or allergic reactions to Tegaderm patches or acrylic adhesives.

Design outcomes

Primary

MeasureTime frame
Skin microbiome analysis 12 weeks Next-Generation Sequencing (16S rRNA gene sequencing)

Secondary

MeasureTime frame
Sebum production 12 weeks Sebumeter,Transepidermal water loss 12 weeks Tewameter,Stratum corneum hydration 12 weeks Corneometer,Skin pH 12 weeks Skin pH meter,Pore size 12 weeks Trica 3D,Porphyrin count 12 weeks Trica 3D

Countries

Thailand

Contacts

Public ContactKunlathorn Thawinprawat

Thammasat University

dr.jame@dejame.co.th0876626116

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026